(Q53315710)

13 May 2018

title

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. (English)

1 reference

13 May 2018

author

Norbert Arnold

9

1 reference

13 May 2018

Kari Hemminki

3

Kari Hemminki

1 reference

13 May 2018

Barbara Wappenschmidt

5

Barbara Wappenschmidt

1 reference

13 May 2018

12

Alfons Meindl

1 reference

13 May 2018

13

Rita K Schmutzler

1 reference

13 May 2018

15

Barbara Burwinkel

1 reference

13 May 2018

6

Peter Bugert

1 reference

13 May 2018

Sandrine Tchatchou

1

Sandrine Tchatchou

1 reference

13 May 2018

Nina Ditsch

11

Nina Ditsch

1 reference

13 May 2018

Raymonda Varon-Mateeva

10

Raymonda Varon-Mateeva

1 reference

13 May 2018

author name string

Anke Jung

2

1 reference

13 May 2018

Christian Sutter

4

1 reference

13 May 2018

Bernhard H F Weber

7

1 reference

13 May 2018

Dieter Niederacher

8

1 reference

13 May 2018

Claus R Bartram

14

1 reference

13 May 2018

language of work or name

English

0 references

publication date

20 November 2008

1 reference

13 May 2018

published in

Carcinogenesis

1 reference

13 May 2018

volume

30

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

59-64

1 reference

13 May 2018

Mechanisms of gene silencing by double-stranded RNA

cites work

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MicroRNAs in vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Camels and zebrafish, viruses and cancer: a microRNA update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MicroRNA-cancer connection: the beginning of a new tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

21 January 2018

MicroRNAs as oncogenes

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Elucidation of the small RNA component of the transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Natural selection on human microRNA binding sites inferred from SNP data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Sequence variants in SLITRK1 are associated with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Epidemiology of cancer: global patterns and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Epidemiology of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

The genetics and genomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

The role of estrogen in mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

New approaches to the endocrine prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Endocrine-responsive breast cancer and strategies for combating resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Expression of the C-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

p21-activated kinase signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

AR and ER interaction with a p21-activated kinase (PAK6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Targeting TACE-dependent EGFR ligand shedding in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Association of NCOA3 polymorphisms with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

ESR1 and EGF genetic variation in relation to breast cancer risk and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogen receptor genotypes and haplotypes associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogen receptors: how do they signal and what are their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Nuclear receptors in disease: the oestrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Hormonal influences on cancer progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Proximal 6q, a region showing allele loss in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

The role of the estrogen receptor in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Estrogen receptor variants in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGN253

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN253

1 reference

13 May 2018

1 reference

13 May 2018